Published in Nutr Metab (Lond) on January 05, 2006
Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease. Cardiol Res Pract (2012) 0.82
The impact of fiber supplementation on ADMA levels. Nutr Clin Pract (2009) 0.75
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet (1994) 9.13
Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation (1999) 8.13
Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A (1991) 8.04
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet (1981) 7.05
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet (1992) 5.36
Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest (1989) 5.01
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation (1998) 3.25
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA (2002) 3.20
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation (1999) 2.77
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation (2002) 2.65
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet (2002) 2.65
Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res (1989) 2.31
Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol (2000) 1.72
Hypertension causes premature aging of endothelial function in humans. Hypertension (1997) 1.70
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res (2003) 1.67
Effects of a Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects. Clin Sci (Lond) (2004) 1.63
Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol (2001) 1.53
Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol (2000) 1.42
Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol (1996) 1.35
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol (1999) 1.32
Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol (1999) 1.31
Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur J Clin Nutr (1999) 1.26
Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem J (1976) 1.22
Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med (2003) 1.19
Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun (1996) 1.19
Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res (2001) 1.17
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol (1996) 1.15
Fish oil and cardiovascular disease: lipids and arterial function. Am J Clin Nutr (2000) 1.15
Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr (2003) 1.14
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol (2001) 1.12
Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med (2001) 1.11
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism (2004) 1.10
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol (2000) 1.07
Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol (2001) 1.04
Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation (1997) 1.04
Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr (2005) 1.00
Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol (1997) 0.97
n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr (1997) 0.95
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. Atherosclerosis (2003) 0.94
Esterification of fatty acids at room temperature by chloroform-methanolic HCl-cupric acetate. J Lipid Res (1973) 0.88
Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia (2002) 0.88
Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol (1997) 0.86
Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors. J Cardiovasc Pharmacol (2003) 0.85
Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am J Physiol (1995) 0.84
n-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Clin Nutr Metab Care (2000) 0.83
Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol (1995) 0.80
Vascular effects of step I diet in hypercholesterolemic patients with coronary artery disease. Am J Cardiol (2003) 0.78
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med (2006) 7.28
Warfarin, aspirin, or both after myocardial infarction. N Engl J Med (2002) 6.85
The anesthesia in abdominal aortic surgery (ABSENT) study: a prospective, randomized, controlled trial comparing troponin T release with fentanyl-sevoflurane and propofol-remifentanil anesthesia in major vascular surgery. Anesthesiology (2013) 3.38
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol (2012) 2.41
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel. Thromb Haemost (2014) 2.29
Low heart rates predict incident atrial fibrillation in healthy middle-aged men. Circ Arrhythm Electrophysiol (2013) 2.12
Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety. Thromb Res (2005) 1.62
Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation. Am J Cardiol (2012) 1.60
Increased circulating mitochondrial DNA after myocardial infarction. Int J Cardiol (2012) 1.58
Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study. Hypertension (2012) 1.57
Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. Am J Cardiol (2007) 1.48
Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol (2005) 1.48
The association between metabolic syndrome and infarct size in patients with acute myocardial infarction. Scand J Clin Lab Invest (2010) 1.45
Candesartan in the prevention of relapsing atrial fibrillation. Int J Cardiol (2006) 1.45
Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation. Eur Heart J (2013) 1.44
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia. Metabolism (2007) 1.42
Less benefit from warfarin in diabetics after myocardial infarction? Cardiology (2008) 1.40
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 1.36
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J (2011) 1.34
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy. Am J Cardiol (2010) 1.30
The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol (2010) 1.23
Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J (2011) 1.23
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting. Thromb Haemost (2009) 1.21
Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J (2005) 1.21
Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am J Physiol Heart Circ Physiol (2005) 1.20
Evaluation of oral mucosal lesions in 598 referred Iranian patients. Open Dent J (2009) 1.19
Patients' experiences with symptoms and needs in the early rehabilitation phase after coronary artery bypass grafting. Eur J Cardiovasc Nurs (2012) 1.17
High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors--a 28-30 years follow-up study. Eur J Cardiovasc Prev Rehabil (2010) 1.15
Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol (2009) 1.15
Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes (2002) 1.14
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism (2004) 1.10
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res (2002) 1.06
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Am J Clin Nutr (2009) 1.02
Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr (2005) 1.00
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.99
Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway. PLoS One (2011) 0.99
Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care (2008) 0.98
Regeneration of the epithelium in organ-cultured donor corneas with extended post-mortem time. Acta Ophthalmol Scand (2007) 0.98
Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J Am Coll Cardiol (2008) 0.98
miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial-mesenchymal transition in pterygium. Exp Eye Res (2013) 0.98
Age and stress related phenotypical changes in bone marrow CD34+ cells. Scand J Clin Lab Invest (2009) 0.95
The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care (2012) 0.95
Regeneration with proliferation of the endothelium of cultured human donor corneas with extended postmortem time. Cornea (2008) 0.94
Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res (2003) 0.94
The influence of a one-step reamer-irrigator-aspirator technique on the intramedullary pressure in the pig femur. Injury (2006) 0.94
Effects of organ culture and Optisol-GS storage on structural integrity, phenotypes, and apoptosis in cultured corneal epithelium. Invest Ophthalmol Vis Sci (2007) 0.94
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. Atherosclerosis (2003) 0.94
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size. Heart (2011) 0.94
Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil (2006) 0.94
No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice. Scand Cardiovasc J (2002) 0.93
Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes. Scand J Clin Lab Invest (2009) 0.93
Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design. Scand Cardiovasc J (2004) 0.92
Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease. Clin Chim Acta (2011) 0.92
Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers. BMC Med (2010) 0.91
Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris. Scand J Clin Lab Invest (2008) 0.90
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness. Metabolism (2013) 0.90
A novel method for preserving cultured limbal epithelial cells. Br J Ophthalmol (2006) 0.90
Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men. Am J Cardiol (2012) 0.90
Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patients. Age Ageing (2010) 0.89
Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis. Med Sci Monit (2003) 0.89
Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study. J Cardiovasc Magn Reson (2011) 0.89
High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial). J Am Heart Assoc (2012) 0.89
Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study. Cardiovasc Diabetol (2011) 0.88
A comparison of the effects of cheese and butter on serum lipids, haemostatic variables and homocysteine. Br J Nutr (2004) 0.88
Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease. Am J Cardiol (2005) 0.88
Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin Sci (Lond) (2003) 0.88
Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol (2004) 0.88
A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil (2010) 0.87
The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome. Metab Syndr Relat Disord (2009) 0.87